0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Pneumococcal Vaccination FREE

Jill Jin, MD, MPH
JAMA. 2015;313(7):758. doi:10.1001/jama.2015.64.
Text Size: A A A
Published online

Pneumococcal vaccination can prevent severe illness and death from pneumococcal disease.

WHY VACCINATE FOR PNEUMOCOCCAL DISEASE?

Pneumococcal disease refers to any infection caused by a type of bacteria called Streptococcus pneumoniae. These bacteria commonly affect the lungs, causing pneumonia, and can also affect the sinuses, ears, and other parts of the airway, causing sinusitis, ear infections, or upper respiratory tract infections. These infections are generally not life threatening.

However, in some people, pneumococcal disease can be severe and life threatening. These are usually cases that affect the brain, causing meningitis, or spread through the bloodstream, causing sepsis. These cases of severe pneumococcal disease, also referred to as invasive pneumococcal disease, can be decreased by getting vaccinated.

WHO SHOULD BE VACCINATED FOR PNEUMOCOCCAL DISEASE?

Children and adults older than 65 years have a higher chance of getting pneumococcal disease. Therefore, vaccination efforts are focused on these 2 groups of people.

Two types of pneumococcal vaccines are currently recommended in the United States. One is the 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23) and the other is the 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13). As of September 2014, the Advisory Committee on Immunization Practices (ACIP) recommends that

  • All children younger than 5 years should get the PCV13 vaccine.

  • All adults aged 65 years or older should get both the PCV13 and the PPSV23 vaccines (but not at the same time).

  • Healthy adults between ages 19 and 65 years do not need to be vaccinated for pneumococcal disease.

  • Some adults between ages 19 and 65 years who have long-term health problems should be vaccinated for pneumococcal disease. Some examples include people with heart disease, lung disease, diabetes, HIV infection, or certain cancers or those who have had surgery on their spleen. Depending on the specific condition, either one or both vaccines should be given. Depending on the person’s age at vaccination, revaccination may be needed after age 65 years.

A doctor can help determine whether you should be vaccinated for pneumococcal disease and which vaccine you should receive. The February 17, 2015, issue of JAMA includes an article with more information on the latest ACIP guidelines for pneumococcal vaccination.

Box Section Ref ID

For More Information

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA’s website at jama.com. Many are available in English and Spanish. A Patient Page on pneumococcal diseases was published in the April 12, 2006, issue of JAMA.

ARTICLE INFORMATION

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

Source: Advisory Committee on Immunization Practices

Topic: Infectious Disease/Preventive Medicine

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Spanish Patient Page: Vacunación antineumocócica

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

7,520 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs